These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30366020)

  • 21. Mechanism of action of salsolinol on tyrosine hydroxylase.
    Briggs GD; Nagy GM; Dickson PW
    Neurochem Int; 2013 Dec; 63(8):726-31. PubMed ID: 24083987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
    Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
    J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
    Richard MG; Bennett JP
    J Neurochem; 1995 May; 64(5):2080-6. PubMed ID: 7722491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol.
    Håkansson K; Pozzi L; Usiello A; Haycock J; Borrelli E; Fisone G
    Eur J Neurosci; 2004 Aug; 20(4):1108-12. PubMed ID: 15305880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.
    Georgievska B; Kirik D; Björklund A
    J Neurosci; 2004 Jul; 24(29):6437-45. PubMed ID: 15269253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-regulated dopamine release from substantia nigra neurons.
    Levin BE
    Brain Res; 2000 Aug; 874(2):158-64. PubMed ID: 10960600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.
    German DC; McMillen BA; Sanghera MK; Saffer SI; Shore PA
    Brain Res Bull; 1981 Feb; 6(2):131-4. PubMed ID: 6110470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
    Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
    Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
    Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
    J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semichronic inhibition of glutathione reductase promotes oxidative damage to proteins and induces both transcription and translation of tyrosine hydroxylase in the nigrostriatal system.
    Romero-Ramos M; Venero JL; Garcia-Rodriguez S; Ayala A; Machado A; Cano J
    Free Radic Res; 2003 Sep; 37(9):1003-12. PubMed ID: 14670008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
    Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.
    Salvatore MF; Waymire JC; Haycock JW
    J Neurochem; 2001 Oct; 79(2):349-60. PubMed ID: 11677263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
    Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
    Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.